FGen: Funding, Investors & Team (Sep 2026)
FGen is a Swiss start-up company founded 2011 in Basel as a spin-off from the Department of Biosystems Science and Engineering of the ETH Zurich. As a contract reasearch organization we collaborate with partners from Biotech, Life Sciences, and Pharma in order to establish efficient bioprocesses and to develop new biopharmaceuticals.
FGen has raised $100k across 1 funding round on record, the most recent a Debt Financing of $100k announced in Dec 2021.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
FGen Company Profile and Key Stats
Latest funding round on record: Dec 2021.
FGen Funding Rounds
FGen Founders and Leadership Team
No contact details are on record for this team yet.
FGen Funding Compared to Other Biotechnology Startups
FGen's latest round of $100k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like FGen in Biotechnology and Basel
Companies Similar to FGen
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…
At Immitra Bio, we are developing a unique genetic medicine platform that combines two of the most powerful…
compliag is providing agile solutions for regulated industries, including the licencing, manufacturing and…
MoonLake Immunotherapeutics is a biopharmaceutical company in the clinical stage that is developing new…
Isospec Analytics SA is a life science company that aims at simplifying molecular identification. We are…
Cria Technologies reinvents cold-chain transport with high-vacuum insulation technology that offers…
Precise Health is a phage therapy platform that specialises in improving and treating bacterial infections to…
AC Immune is a biopharmaceutical company based in Switzerland that is currently in the clinical stage. They…
AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at…
Combioxin SA is clinical-stage biotech company developing innovative anti-virulence drugs to treat severe…
MindMaze is a digital neurotherapeutic platform that provides digital assessments and therapeutics to treat…
Neurosoft Bioelectronics is developing next-generation soft implantable electrodes to interface with the…
FGen Funding FAQs
What does FGen do?
FGen is a Swiss start-up company founded 2011 in Basel as a spin-off from the Department of Biosystems Science and Engineering of the ETH Zurich. As a contract reasearch organization we collaborate with partners from Biotech, Life Sciences, and Pharma in order to establish efficient bioprocesses and to develop new biopharmaceuticals.
How much funding has FGen raised?
FGen has raised $100k across 1 round on record. The most recent is a Debt Financing of $100k announced in Dec 2021.
When did FGen last raise funding?
FGen's most recent funding round on record is a Debt Financing of $100k, announced in Dec 2021.
Who is the CEO of FGen?
Andreas Meyer is listed as CEO at FGen.
Where is FGen headquartered?
FGen is based in Basel, Basel-Stadt, Switzerland.
How many employees does FGen have?
FGen is in the 11-50 employee band.
How does FGen's funding compare to other Biotechnology startups?
FGen's latest round of $100k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's FGen Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for FGen is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.